Your Health Plan:
Your Health Plan:
Not SelectedEGRIFTA SV (tesamorelin acetate) is a biologic prescription drug for treatment of Lipodystrophy. EGRIFTA SV is a growth hormone releasing factor analog. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $5700-6900.
No other option is found for EGRIFTA SV